Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'tranylcypromine 2 pcpa hcl'

Search results for: 'tranylcypromine 2 pcpa hcl'

Items 31-40 of 46

Page
per page
  1. LY2801653
    A3573 LY2801653
    Target: MET
    Summary: MET inhibitor
      ≥27.65 mg/mL
  2. Nintedanib (BIBF 1120)
    A8252 Nintedanib (BIBF 1120)
     3 Citation
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL
  3. GS-9973
    B3553 GS-9973
    Target: Syk
    Summary: Syk inhibitor, orally bioavailable and selective
      insoluble in EtOH; insoluble in H2O; ≥20.55 mg/mL
  4. Axitinib (AG 013736)
    A8370 Axitinib (AG 013736)
     1 Citation
    Target: VEGFR|PDGFR|c-Kit
    Summary: VEGFR1/ c-Kit inhibitor
      insoluble in H2O; ≥19.3 mg/mL
  5. GNE0877
    B4633 GNE0877
    Target: LRRK2
    Summary: Potent and selective LRRK2 inhibitor
      ≥21 mg/mL
  6. AG-1478
    A8357 AG-1478
    Target: EGFR
    Summary: EGFR inhibitor,potent and selective
      insoluble in H2O; ≥15.8 mg/mL
  7. HG-10-102-01
    B1262 HG-10-102-01
     1 Citation
    Target: LRRK2
    Summary: LRRK2 inhibitor
      insoluble in H2O; ≥18.9 mg/mL
  8. LDN-193189
    A8324 LDN-193189
    Target: BMP and Other Activin Receptors
    Summary: ALK inhibitor,potent and selective
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  9. NVP-BHG712
    A8683 NVP-BHG712
    Target: Eph Receptors|VEGFR
    Summary: EphB4 inhibitor,potent and selective
      ≥25.15 mg/mL
  10. Sorafenib Tosylate
    A8245 Sorafenib Tosylate
     1 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥31.85 mg/mL

Items 31-40 of 46

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 1 item
  2. Axl 1 item
  3. ALK 1 item
  4. Broad Spectrum Protein Kinase Inhibitor 1 item
  5. c-FMS 1 item
  6. c-Kit 1 item
  7. c-MET 5item
  8. c-RET 1 item
  9. CSF-1R 1 item
  10. EGFR 8item
  11. FAK 3item
  12. FGFR 4item
  13. HER2 3item
  14. LRRK2 3item
  15. PDGFR 6item
  16. Pyk2 2item
  17. Spleen Tyrosine Kinase (Syk) 2item
  18. Src 2item
  19. Tie-2 2item
  20. Trk 1 item
  21. VEGFR 11item
Reversibility
  1. Reversible 5item
  2. Irreversible 2item
Target
  1. Raf 3item
  2. CSF-1R 1 item
  3. FLT3 3item
  4. Eph Receptors 1 item
  5. VEGFR 16item
  6. PDGFR 6item
  7. c-Kit 4item
  8. RET 2item
  9. Bcr-Abl 1 item
  10. FGFR 4item
  11. MET 4item
  12. Src 1 item
  13. Trk Receptors 2item
  14. EGFR 7item
  15. FAK 3item
  16. BMP and Other Activin Receptors 1 item
  17. Syk 2item
  18. ErbB 2item
  19. c-MET 2item
  20. PKC 1 item
  21. Pyk2 3item
  22. LRRK2 3item
  23. PKG 1 item
  24. PKA 1 item
  25. Myosin light chain kinases (MLCKs) 1 item
  26. Tie-2 2item
  27. Flk-1 1 item
  28. c-Fms tyrosine kinase 1 item
  29. Lyn kinase 1 item
  30. DCLK2 1 item
Reported Experiments
  1. Animal Experiments 43item
  2. Cell Experiments 28item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Bladder Cancer 3item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 10item
  7. Cancer 34item
  8. Cholangiocarcinoma 1 item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Clear Cell Renal Cell Carcinoma 1 item
  11. Colon Cancer 2item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 7item
  14. Glioblastoma 3item
  15. Glioma 2item
  16. Hepatocellular Carcinoma 2item
  17. Liver Cancer 2item
  18. Lung Cancer 3item
  19. Lung Carcinoma 1 item
  20. Lymphoma 1 item
  21. Melanoma 2item
  22. Multiple Myeloma 3item
  23. Non-small Cell Lung Cancer 3item
  24. Ovarian Cancer 2item
  25. Pancreatic Cancer 7item
  26. Prostate Cancer 3item
  27. Renal Cancer 1 item
  28. Renal Cell Carcinoma 3item
  29. Thyroid Cancer 3item